Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) have been changing the paradigm of cancer treatment. However, immune-related adverse effects (irAEs) have also increased with the exponential increase in the use of ICIs. ICIs can break up the immunologic homeostasis and reduce T-cell tolerance. Therefore, inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Juwhan, Lee, Sung Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Immunologists 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049586/
https://www.ncbi.nlm.nih.gov/pubmed/32158597
http://dx.doi.org/10.4110/in.2020.20.e9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049586/
https://www.ncbi.nlm.nih.gov/pubmed/32158597
http://dx.doi.org/10.4110/in.2020.20.e9

Ejemplares similares